Christopher W. Plummer
17Patents
2h-index
84Co-inventors
57Inventor score
Filing activity: Jul 17, 2002 → Mar 31, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9957219B2 | Antidiabetic bicyclic compounds | Chemistry; Metallurgy | 5 | Active |
| US9527875B2 | Antidiabetic tricyclic compounds | Chemistry; Metallurgy | 3 | Active |
| US10100042B2 | [5,6]—fused bicyclic antidiabetic compounds | Chemistry; Metallurgy | 2 | Active |
| US7057051B2 | Substituted imidazoles as cannabinoid receptor modulators | Chemistry; Metallurgy | 2 | Expired |
| US7572785B2 | Substituted imidazoles as cannabinoid receptor modulators | Chemistry; Metallurgy | 1 | Active |
| US11230543B2 | Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections | Emerging Cross-Sectional Technologies | 1 | Active |
| US9840512B2 | Antidiabetic bicyclic compounds | Chemistry; Metallurgy | 1 | Active |
| US10968193B2 | Antidiabetic bicyclic compounds | Chemistry; Metallurgy | 1 | Active |
| US11312719B2 | 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use | Emerging Cross-Sectional Technologies | 1 | Active |
| US12060357B2 | 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use | Emerging Cross-Sectional Technologies | 0 | Active |
| US12263171B2 | 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use | Chemistry; Metallurgy | 0 | Active |
| US10131651B2 | [7,6]-fused bicyclic antidiabetic compounds | Chemistry; Metallurgy | 0 | Active |
| US7091211B2 | Cyclopentyl modulators of chemokine receptor activity | Chemistry; Metallurgy | 0 | Expired |
| US10662171B2 | Antidiabetic bicyclic compounds | Chemistry; Metallurgy | 0 | Active |
| US10059667B2 | Antidiabetic compounds | Chemistry; Metallurgy | 0 | Active |
| US11161819B2 | Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists | Chemistry; Metallurgy | 0 | Active |
| US10000454B2 | Antidiabetic tricyclic compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.